Chang-Yuil Kang 1 페이지

본문 바로가기
사이트 내 전체검색
About us

Clinical Translation
Anti-tumor immunotheraphy, tolerance, asthma, mucosal vaccination
Prof. Chang-Yuil Kang
Current Research Interests
A two-pronged approach, generating effective immune responses against tumor antigen and overcoming tumor-immune suppressive environment, is required for successful cancer immunotherapy. For this, we are developing the strategies to elicit potent anti-cancer immune responses and to get over immune suppressive environment.
T cell and NKT cell
IL-17-secreting T cells represent a distinct CD4+ effector T cell lineage (Th17) that appears to be essential in the pathogenesis of numerous inflammatory and autoimmune diseases. We are studying Th17 cells in mouse and human system to characterize their immunological properties and identify new targets necessary for their generation or maintenance.
In addition, we are studying various features of natural killer T cells (NKT cells) which have a critical role in both innate and adaptive immunity. We are also studying the relationship of NKT cells with regulatory T cells.
mmune tolerance
We are studying the mechanism of immune tolerance in the periphery especially in the intestine. In this regard, our research focuses on the role of various immune cells that reside in lymphoid and non-lymphoid organs in developing immune tolerance against intestinal antigens. Also, we are studying the characteristics of diverse CD4+ T cells bearing immuno-modulating activities including Foxp3+ regulatory T cells and their role in peripheral tolerance.
GITR drives TH9-mediated antitumor immunity
A multimeric carcinoembryonic antigen signal inhibits the activation of human T cells by a SHP-independent mechanism: a potential mechanism for tumor-mediated suppression of T-cell immunity
Tumor-Derived Osteopontin Suppresses Antitumor Immunity by Promoting Extramedullary Myelopoiesis
Enhancing T Cell Immune Responses by B Cell-based Therapeutic Vaccine Against Chronic Virus Infection.
Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells

Main Campus Gwanak1 Gwanak-ro, Gwanak-gu, Seoul 08826,Korea Tel82-2-880-8141 Fax82-2-872-0630
Medical Campus Yeongun103 Daehak-ro, Jongno-gu Seoul 03080Tel82-2-740-8923, 8554
Copyright ⓒ 2016 MMBS, SEOUL NATIONAL UNIVERSITY. All rights Reserved.